A Brake Becomes an Accelerator: PTP1B—A New Therapeutic Target for Breast Cancer
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 11 (3) , 214-216
- https://doi.org/10.1016/j.ccr.2007.02.022
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Protein-Tyrosine Phosphatase 1B Is Required for HER2/Neu–Induced Breast CancerCancer Research, 2007
- The role of Shp2 (PTPN11) in cancerCurrent Opinion in Genetics & Development, 2007
- Role of Src Kinases in Neu-Induced Tumorigenesis: Challenging the Paradigm Using Csk Homologous Kinase Transgenic MiceCancer Research, 2006
- COMPARTMENTALIZED RAS/MAPK SIGNALINGAnnual Review of Immunology, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- The role of protein tyrosine phosphatase 1B in Ras signalingProceedings of the National Academy of Sciences, 2004
- PTP1B: From the sidelines to the front lines!FEBS Letters, 2003
- CD45: A Critical Regulator of Signaling Thresholds in Immune CellsAnnual Review of Immunology, 2003
- Imaging Sites of Receptor Dephosphorylation by PTP1B on the Surface of the Endoplasmic ReticulumScience, 2002
- Identification of Protein-tyrosine Phosphatase 1B as the Major Tyrosine Phosphatase Activity Capable of Dephosphorylating and Activating c-Src in Several Human Breast Cancer Cell LinesJournal of Biological Chemistry, 2000